FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $210,000 | +191.7% | 5,600 | +31.2% | 0.00% | – |
| Q4 2020 | $72,000 | +157.1% | 4,268 | -28.7% | 0.00% | – |
| Q3 2020 | $28,000 | -22.2% | 5,989 | 0.0% | 0.00% | – |
| Q2 2020 | $36,000 | -90.6% | 5,989 | -92.9% | 0.00% | -100.0% |
| Q4 2019 | $385,000 | +19150.0% | 84,321 | +16764.2% | 0.00% | – |
| Q3 2019 | $2,000 | -98.2% | 500 | -94.1% | 0.00% | – |
| Q1 2019 | $114,000 | +776.9% | 8,500 | +507.1% | 0.00% | – |
| Q4 2018 | $13,000 | -84.9% | 1,400 | -77.4% | 0.00% | – |
| Q3 2018 | $86,000 | -16.5% | 6,200 | -4.6% | 0.00% | – |
| Q2 2018 | $103,000 | -15.6% | 6,500 | -8.5% | 0.00% | – |
| Q1 2018 | $122,000 | -71.3% | 7,100 | -62.4% | 0.00% | -100.0% |
| Q4 2017 | $425,000 | -48.0% | 18,869 | -5.5% | 0.00% | 0.0% |
| Q3 2017 | $817,000 | -40.3% | 19,970 | -56.1% | 0.00% | -50.0% |
| Q2 2017 | $1,369,000 | -59.2% | 45,466 | -51.0% | 0.00% | -66.7% |
| Q1 2017 | $3,355,000 | -64.5% | 92,809 | -50.3% | 0.01% | -66.7% |
| Q4 2016 | $9,443,000 | – | 186,732 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|